187. THERAPEUTIC MYELOPEROXIDASE INHIBITION ATTENUATES NEUTROPHIL ACTIVATION, ANCA-MEDIATED ENDOTHELIAL DAMAGE AND CRESCENTIC GLOMERULONEPHRITIS. (29th March 2019)